Academic literature on the topic 'Insulin Treated Diabetic'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Insulin Treated Diabetic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Insulin Treated Diabetic"

1

Macedo, Célia Sperandéo, Sonia Maria Capelletti, Maria Cecília Salgado Mercadante, Carlos Roberto Padovani, and César Tadeu Spadella. "Role of metabolic control on diabetic nephropathy." Acta Cirurgica Brasileira 17, no. 6 (2002): 370–76. http://dx.doi.org/10.1590/s0102-86502002000600003.

Full text
Abstract:
OBJECTIVE: The aim of this investigation was studying the influence of glucose metabolic control on diabetic nephropathy. The authors observed the effect of acarbose, insulin, and both drugs on the metabolic control and development of mesangial enlargement of kidney glomeruli in alloxan-diabetic rats. METHODS: Five groups of Wistar rats were used: normal rats (N), non-treated alloxan-diabetic rats (D), alloxan-diabetic rats treated with acarbose (AD), alloxan-diabetic rats treated with insulin (ID), and alloxan-diabetic rats treated with insulin plus acarbose (IAD). The following parameters we
APA, Harvard, Vancouver, ISO, and other styles
2

Kobayashi, Tsuneo, and Katsuo Kamata. "Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats." American Journal of Physiology-Heart and Circulatory Physiology 283, no. 5 (2002): H1761—H1768. http://dx.doi.org/10.1152/ajpheart.00248.2002.

Full text
Abstract:
We investigated the relationship between the changes in vascular responsiveness and growth factor mRNA expressions induced by 1-wk treatment with high-dose insulin in control and established streptozotocin (STZ)-induced diabetes. Aortas from diabetic rats, but not those from insulin-treated diabetic rats, showed impaired endothelium-dependent relaxation in response to ACh (vs. untreated controls). The ACh-induced nitrite plus nitrate (NOx) level showed no significant difference between controls and diabetics. Insulin treatment increased NOx only in diabetics. In diabetics, insulin treatment si
APA, Harvard, Vancouver, ISO, and other styles
3

Gargiulo, P., U. Di Mario, O. Zuccarini, et al. "Treatment of diabetic pregnant women with monocomponent insulins." Acta Endocrinologica 113, no. 3_Suppl (1986): S60—S65. http://dx.doi.org/10.1530/acta.0.111s0060.

Full text
Abstract:
Abstract. Very little immunological research has been undertaken in pregnant diabetic women in relation to insulin therapy. We investigated the relations between treatment with insulins of varied immunogenic character and the presence of immune factors such as insulin antibodies, immune complexes and insulin antiinsulin complexes as well as some maternal and neonatal complications of diabetic pregnancy. 128 insulin treated diabetic pregnant women and 121 of their newborns were included in the study. The incidence of insulin antibodies, immune complexes and insulin antiinsulin complexes was low
APA, Harvard, Vancouver, ISO, and other styles
4

Dzhavakhishvili, T. S., T. I. Romantsova, and O. V. Roik. "Influence of the dynamics of body weight on the risk factors of cardiovascular disease in patients with type 2 diabetes during the first year of insulin treatment." Obesity and metabolism 10, no. 1 (2013): 22–25. http://dx.doi.org/10.14341/2071-8713-5067.

Full text
Abstract:
The aim of the present study was to investigate whether insulin treatment-induced weight gain had an adverse impact on cardiovascular risk factors in insulin-treated type 2 diabetic patients during the first year after initiating insulin therapy when insulin analogues or human insulins are used. A total of 157 patients with newly insulinized type 2 diabetes were included in the study. The patients were divided in two groups. First group consisted of subjects (mean age 57 [45; 73], duration of diabetes of 10 years [4; 16]) who had received long-acting basal (glargine, detemir), premixed (biphas
APA, Harvard, Vancouver, ISO, and other styles
5

Naquet, P., J. Ellis, D. Tibensky, et al. "T cell autoreactivity to insulin in diabetic and related non-diabetic individuals." Journal of Immunology 140, no. 8 (1988): 2569–78. http://dx.doi.org/10.4049/jimmunol.140.8.2569.

Full text
Abstract:
Abstract T cell autoreactivity to insulin in type I diabetic and related non-diabetic individuals was analyzed. Peripheral T lymphocytes from both insulin-treated diabetic and untreated non-diabetic members of four families were found to proliferate in vitro in response to human insulin. T cell autoreactivity to insulin therefore does not appear to be diagnostic of the onset of type I diabetes. Highest T cell responses to human insulin were usually detected in insulin-dependent type I diabetes patients treated with a mixture of beef and pork insulin than with self insulin, the greater the dose
APA, Harvard, Vancouver, ISO, and other styles
6

Ige, Abayomi Oluwatosin, Olanrewaju Amos Ajayi, and Eunice Olufunke Adewoye. "Anti-inflammatory and insulin secretory activity in experimental type-2 diabetic rats treated orally with magnesium." Journal of Basic and Clinical Physiology and Pharmacology 29, no. 5 (2018): 507–14. http://dx.doi.org/10.1515/jbcpp-2017-0104.

Full text
Abstract:
Abstract Background Diabetes mellitus causes low-grade chronic inflammation which leads to the development of long-term complications. Oral magnesium (Mg) intake amongst other effects was reported to reduce the levels of inflammatory markers. This study investigated the anti-inflammatory and insulin secretory activities in experimental type-2 diabetic rats (n=32) orally treated with Mg. Methods Experimental type-2 diabetic rats were induced with high fat diet and alloxan (50 mg/kg, single i.p.) for over 10 weeks prior to the experimental procedures. Male Wistar rats were divided into 4 equal g
APA, Harvard, Vancouver, ISO, and other styles
7

Bellush, L. L., and S. G. Reid. "Metabolic and neurochemical profiles in insulin-treated diabetic rats." American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 266, no. 1 (1994): R87—R94. http://dx.doi.org/10.1152/ajpregu.1994.266.1.r87.

Full text
Abstract:
Plasma glucose concentration was measured at 3-h intervals in streptozotocin-induced diabetic rats placed on various insulin replacement regimens using three different kinds of insulin. High insulin dosages produced at least periodic hypoglycemia, even though there were no overt signs of insulin overdose. Low- and single-dose regimens produced periods of hyperglycemia. Both high and low doses of protamine zinc insulin normalized diabetes-induced reductions in 5-hydroxyindole-3-acetic acid [5-HIAA; the principal metabolite of 5-hydroxytryptamine (5-HT)] and 5-HT turnover (5-HIAA/5-HT), despite
APA, Harvard, Vancouver, ISO, and other styles
8

Ishida, Hitoshi, Yutaka Seino, Shigeo Nishi, et al. "Effects of insulin on altered mineral and vitamin D metabolism in streptozotocin-induced diabetes." Acta Endocrinologica 108, no. 2 (1985): 231–36. http://dx.doi.org/10.1530/acta.0.1080231.

Full text
Abstract:
Abstract. In order to ascertain whether or not abnormal mineral and vitamin D metabolism in diabetes can be reversed by insulin therapy, plasma calcium, ionized calcium, phosphorus, parathyroid hormone (PTH) and vitamin D metabolites were measured in control, streptozotocin (STZ) diabetic and insulin-treated diabetic rats. Blood glucose levels in diabetic rats treated with insulin decreased to normal. The low plasma calcium and ionized calcium levels in diabetic rats were found to be normal in insulin-treated diabetic rats. An elevated PTH level was observed in the diabetic group, but it was a
APA, Harvard, Vancouver, ISO, and other styles
9

Qin, Bolin, Masaru Nagasaki, Ming Ren, Gustavo Bajotto, Yoshiharu Oshida, and Yuzo Sato. "Gosha-jinki-gan (a Herbal Complex) Corrects Abnormal Insulin Signaling." Evidence-Based Complementary and Alternative Medicine 1, no. 3 (2004): 269–76. http://dx.doi.org/10.1093/ecam/neh028.

Full text
Abstract:
Previous studies have shown that the traditional herbal complex Gosha-jinki-gan (GJG) improves diabetic neuropathy and insulin resistance. The present study was undertaken to elucidate the molecular mechanisms related with the long-term effects of GJG administration on insulin actionin vivoand the early steps of insulin signaling in skeletal muscle in streptozotocin (STZ) diabetes. Rats were randomized into five subgroups: (1) saline treated control, (2) GJG treated control, (3) 2-unit insulin + saline treated diabetic, (4) saline + GJG treated diabetic and (5) 2-unit insulin + GJG treated dia
APA, Harvard, Vancouver, ISO, and other styles
10

Ristic, Petar, Maja Savic, Sergey Bolevich, et al. "Examining the Effects of Hyperbaric Oxygen Therapy on the Cardiovascular System and Oxidative Stress in Insulin-Treated and Non-Treated Diabetic Rats." Animals 13, no. 18 (2023): 2847. http://dx.doi.org/10.3390/ani13182847.

Full text
Abstract:
Background: This study explored the effects of hyperbaric oxygen therapy (HBOT) on the cardiovascular system and oxidative stress in streptozotocin-induced diabetic rats. Wistar albino rats were divided into four groups: DM group (diabetic rats), DM+HBOT group (diabetic rats exposed to HBOT for 1 h daily, five days a week, at 2.8 atmosphere absolute (ATA) with 100% oxygen for two weeks), DM+INS group (diabetic rats treated with neutral protamine hagedorn (NPH) insulin at a dosage of 3–5 U/day), and DM+HBOT+INS group (diabetic rats treated with both NPH insulin and HBOT for two weeks). Methods:
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Insulin Treated Diabetic"

1

Tada, Tomohisa. "Comparison of Three-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation Among Insulin-Treated Diabetic, Non-Insulin-Treated Diabetic, and Non-Diabetic Patients from j-Cypher Registry." Kyoto University, 2013. http://hdl.handle.net/2433/180351.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Knights, Penelope Anne. "Magnesium status in normal and diabetic pregnancy : pregnancy outcome and lactation." Thesis, University of Wolverhampton, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.263332.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Woodman, Richard John. "The independent effects of purified EPA and DHA supplementation on cardiovascular risk in treated-hypertensive type 2 diabetic individuals." University of Western Australia. School of Medicine and Pharmacology, 2003. http://theses.library.uwa.edu.au/adt-WU2003.0028.

Full text
Abstract:
[Formulae and special characters can only be approximated here. Please see the pdf version of the Abtract for an accurate reproduction.] Type 2 diabetes at least doubles the risk of cardiovascular disease. This can partly be explained by the increased prevalence of risk factors such as hypertension, dyslipidaemia and obesity. However, the underlying abnormality of insulin resistance and the presence of more recently identified risk factors including endothelial dysfunction, increased inflammation, and increased oxidative stress might also contribute towards the heightened cardiovascular risk
APA, Harvard, Vancouver, ISO, and other styles
4

Siddaramaiah, Naveen Hullekere. "Glycaemic variation in insulin treated diabetic patients with end stage renal disease on maintenance haemodialysis and its effect on cardiac electrical activity." Thesis, University of Newcastle upon Tyne, 2018. http://hdl.handle.net/10443/4103.

Full text
Abstract:
Diabetic kidney disease remains the single most common cause of renal failure in UK, accounting for 26.9% of patients needing renal replacement therapy (UK renal registry, 2016). Mortality rates on RRT are worse for the diabetes population compared to the non-diabetic population. Diabetic patients on maintenance haemodialysis experience huge variation in their glycaemia, which is not well understood to guide appropriate therapy. ESRD patients are at higher risk of sudden cardiac death and arrhythmia is suspected to be a major cause. However there is no established guideline in detecting at ris
APA, Harvard, Vancouver, ISO, and other styles
5

Potts, Jennifer Lucy. "Lipoprotein metabolism in human adipose tissue." Thesis, University of Oxford, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334875.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tudor, Romulus Silviu. "A decision support system for insulin-dose adjustment in insulin-treated subjects with type 2 diabetes mellitus." Thesis, City University London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.274526.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

梁心銘 and Sum-ming Leung. "Use of self monitoring of blood glucose in glycaemic control of non-insulin treated type 2 diabetes mellitus patients." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2008. http://hub.hku.hk/bib/B40721127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Leung, Sum-ming. "Use of self monitoring of blood glucose in glycaemic control of non-insulin treated type 2 diabetes mellitus patients." Click to view the E-thesis via HKUTO, 2008. http://sunzi.lib.hku.hk/hkuto/record/B40721127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Cameron, Dawn M. "Exploring the application of self-monitoring of blood glucose results in insulin-treated diabetes : a case study of patients, their support persons and health care practitioners." Thesis, University of Stirling, 2016. http://hdl.handle.net/1893/25311.

Full text
Abstract:
Self-monitoring of blood glucose (SMBG) can be effective in preventing poor outcomes associated with diabetes mellitus but previous research has identified that SMBG is not being undertaken in line with current recommendations. Guidance informs health professionals to educate patients on how they should self-monitor but very little is know about how patients self-monitor in the real world. In this thesis, a quantitative scoping study is first presented. This study used routine data sources to examine the levels and patterns of self-montoring in different population groups and then proceeded to
APA, Harvard, Vancouver, ISO, and other styles
10

Wade, Alisha. "The effect of blood glucose self-monitoring in patients with non-insulin treated type 2 diabetes." Thesis, University of Oxford, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.517114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Insulin Treated Diabetic"

1

Sjølie, Anne Katrin. Ocular complications in insulin treated diabetes mellitus: An epidemiological study. Script, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Association, British Diabetic, ed. Living with diabetes: The British Diabetic Association guide for those treated with insulin. J. Wiley, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ikuma, Edmond K. Driving with insulin-treated diabetes. Legislative Reference Bureau, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Katherine, Faulks, and Australian Institute of Health and Welfare., eds. Insulin-treated diabetes in Australia 2000-2007. Australian Institute of Health and Welfare, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Heller, Simon. Stratifying hypoglycaemic event risk in insulin-treated diabetes. Department for Transport, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vanderpump, Samantha. Hypoglycaemia and insulin treated Type 2 diabetes mellitus: Two insulin regimes compared. University of Surrey Roehampton, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Broadhurst, C. Leigh. Prevent, treat and reverse diabetes: Vegetarian nutritional guidelines for Type II diabetics. Alive Books, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Day, John L. Living with diabetes: The Diabetes UK guide for those treated with diet and tablets. Wiley, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

United States. Federal Motor Carrier Safety Administration. Office of Research and Technology. Qualifying individuals with insulin-treated diabetes to operate commercial motor vehicles. U.S. Dept. of Transportation, Federal Motor Carrier Safety Administration, Office of Research and Technology, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

ZZ, JL ZZ Day. ZZ Living with Diabetes - The British Diabetic Association Guide for Those Treated with Insulin ZZ. John Wiley and Sons, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Insulin Treated Diabetic"

1

Hedïng, Lise G. "Determination of Total Serum Insulin (IRI) in Insulin-treated Diabetic Patients." In Radioimmunoassays for Insulin, C-Peptide and Proinsulin. Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-011-7094-9_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Lehmann, E. D., T. Deutsch, E. R. Carson, and P. H. Sōnksen. "A Metabolic Prototype to Assist in the Management of Insulin-Treated Diabetic Patients." In Medical Informatics Europe 1991. Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-642-93503-9_190.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Burden, AC ‘Felix’. "Allergy to human insulin – treated with pork insulin in a vegetarian." In Case Studies in Diabetes. CRC Press, 2023. https://doi.org/10.1201/9781003421337-10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Heding, Lise G. "Insulin, C-peptide, and Pro insulin in Nondiabetics and Insulin-treated Diabetics." In Radioimmunoassays for Insulin, C-Peptide and Proinsulin. Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-011-7094-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rose, Stephen J., Manju Bushi, Inderjeet Nagra, and W. Ewart Davies. "Taurine Fluxes in Insulin Dependent Diabetes Mellitus and Rehydration in Streptozotocin Treated Rats." In Advances in Experimental Medicine and Biology. Springer US, 2002. http://dx.doi.org/10.1007/0-306-46838-7_55.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hanefeld, Markolf, and Petra Ott. "A case of type 1 diabetes treated with CSII with progressive decrease of insulin requirement and severe hypoglycaemic episodes." In Case Studies in Diabetes. CRC Press, 2023. https://doi.org/10.1201/9781003421337-11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Profozić, V., M. Koselj, H. Schulz, M. Granić, I. Hillebrand, and Z. Skrabalo. "Effect of Acarbose in Type II Diabetics Treated with Diet Alone, with Diet, and with Sulfonylurea, Diet, and Insulin." In Acarbose for the Treatment of Diabetes Mellitus. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73583-7_41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Dezaki, Katsuya, Boldbaatar Damdindorj, Tomoyuki Kurashina, and Toshihiko Yada. "Ghrelin’s Novel Signaling in Islet β-Cells to Inhibit Insulin Secretion and Its Blockade As a Promising Strategy to Treat Type 2 Diabetes." In Ghrelin in Health and Disease. Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-903-7_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lehmann, Roger. "Diabetes Mellitus." In Manual of Cardiovascular Medicine. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780198850311.003.0006.

Full text
Abstract:
Diabetes mellitus may present as type 1 (juvenile diabetes) or type 2 diabetes. While the former is due to a lack of insulin secretion, type 2 diabetes is due to insulin resistance and only at later stages reduced insulin secretion. Diabetes is defined as a plasma glucose ≥ 11.1 mmol/L at any time or fasting plasma glucose ≥ 7 mmol/L, or a plasma glucose ≥ 11.1 mmol/L 2 h after 75 g oral glucose or haemoglobin A1c ≥ 6.5%. Type 2 diabetes is one of the major cardiovascular risk factors leading to myocardial infarction, stroke, and premature death. It occurs more frequently with increasing body
APA, Harvard, Vancouver, ISO, and other styles
10

Rimmalapudi, Deepthi, and Eli Ipp. "Case 13: Rapid-Onset Type 1 Diabetes and Ketoacidosis." In Diabetes In Practice: Case Studies with Commentary. American Diabetes Association, 2021. http://dx.doi.org/10.2337/9781580407663.13.

Full text
Abstract:
A 54-year-old Hispanic male presented to the emergency department with a 2-day history of nausea, vomiting, polydipsia, and generalized weakness. He was found to be in severe diabetic ketoacidosis with serum glucose of 1,062 mg/dL, pH of 6.84, HCO3 of 5 mmol/L, anion gap of 25, and β-hydroxybutyrate of 11 mmol/L. He denied a previous history of diabetes, but was told 1 year earlier that he had prediabetes and was treated with diet. He was managed in the intensive care unit (ICU) with fluid and electrolyte resuscitation and insulin infusion and was switched to a basal-bolus insulin regimen once
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Insulin Treated Diabetic"

1

Nowak-Göttl, U., W. D. Kreuz, M. John, et al. "HAEMOSTASEOLOGICAL CHANGES IN DIABETIC CHILDREN (HUMAN INSULIN VERSUS PORCINE INSULIN." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643099.

Full text
Abstract:
Changes of haemostaseological parameters are involved in pathogenesis of diabetic angiopathy. However it is not yet clear whether they are cause or consequence of the endothelial damage. We investigated coagulation parameters in 84 children with type I diabetes mellitus without clinical signs of vascular disease.Compared to the control group no significant changes could be seen in fibrinogen, plasminogen, protein C, α 1 antichymotrypsin, β-thrombo-globulin and ristocetin - induced aggregation.Additionally we could observe significant differences in patients treated with human insulin to those
APA, Harvard, Vancouver, ISO, and other styles
2

IL, Nikitina, Liskina AS, Polyanskaya AA, Konoplya IS, and Popova PV. "P194 Metabolic and physical conditions in offspring of diabetic pregnancies treated with insulin." In 8th Europaediatrics Congress jointly held with, The 13th National Congress of Romanian Pediatrics Society, 7–10 June 2017, Palace of Parliament, Romania, Paediatrics building bridges across Europe. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health, 2017. http://dx.doi.org/10.1136/archdischild-2017-313273.282.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Aldali, Sara Haitham, and Sownd Sankaralingam. "Induction of Glyoxalase 1 to prevent Methylglyoxal-Induced Insulin Resistance in Cardiomyocytes." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2020. http://dx.doi.org/10.29117/quarfe.2020.0230.

Full text
Abstract:
Background: Type 2 Diabetes mellitus is characterized by hyperglycemia and insulin resistance. Methylglyoxal (MG) a highly reactive dicarbonyl compound is also increased in diabetes. MG is detoxified by glyoxalase 1 (Glo-1) enzyme using reduced glutathione (GSH) as a co-factor. MG has been shown to have deleterious effects on cardiovascular cells and impairs insulin signaling. Insulin resistance is associated with diabetic cardiomyopathy. Trans-resveratrol (tRES) and Hesperetin (HES) combination has been shown to increase Glo-1 and improve insulin signaling in obese patients. Aim(s): The aim o
APA, Harvard, Vancouver, ISO, and other styles
4

Samama, M., and C. E. Baudoin. "EFFECT OF ASPIRIN AND ASPIRIN COMBINED WITH DIPYRIDAMOLE IN EARLY DIABETIC RETINOPATHY." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643855.

Full text
Abstract:
In a double blind randomised controlled clinical trial the effect of antiplatelet agents (aspirin 330 mg × 3 × day) or in combination with dipyridamole (75 mg 3 × day) versus placebo, was tested in 475 patients with early diabetic retinopathy. Patients were follewed fourmonthly for 3 years. Ophtalmological examinations were carried out initially and at yearly intervals. The assessment of retinopathy was based on changes in the number of microaneurysms (MA) present in the macular field as seen on fluorescein angiograms over a period of three years. Forty one patients did not complete the study.
APA, Harvard, Vancouver, ISO, and other styles
5

Almeida, Juliana, and Fernanda Almeida. "AN UPDATE ON THE ASSOCIATION BETWEEN TYPE 2 DIABETES AND ALZHEIMER- A SYSTEMATIC REVIEW." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda076.

Full text
Abstract:
Background: The association of Type 2 Diabetes (T2D) and Alzheimer’s Disease (AD), that is 6th cause of death in United States, have been long noted. The history of T2D increases the risk for AD by 50-200% and the 10 years risk in 10-30%, which is 25-35 times the general. Objective: To investigate findings of the last 5 years that directly correlate T2D with AD. Methods: Use of the PICO strategy, conducted on September 17, on PubMed using “Alzheimer disease” and “diabetes mellitus” as descriptors, identifying 14 articles, selecting 4 after screening. Inclusion criteria: clinical and randomized
APA, Harvard, Vancouver, ISO, and other styles
6

Olsson, Håkan, Rickard Einefors, Per Broberg, and Mona Landin Olsson. "Abstract P4-11-02: Worse breast cancer prognosis in insulin treated diabetic patients - A population based registry study in Sweden." In Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium; December 9-13, 2014; San Antonio, TX. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.sabcs14-p4-11-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

SAMAN, Thiago Abreu, Isabelle Medeiros RODRIGUES, and Mário dos Santos FILHO. "THE EVOLUTION OF CATARACT IN A DOG WITH TYPE I DIABETES - CASE REPORT." In SOUTHERN BRAZILIAN JOURNAL OF CHEMISTRY 2021 INTERNATIONAL VIRTUAL CONFERENCE. DR. D. SCIENTIFIC CONSULTING, 2022. http://dx.doi.org/10.48141/sbjchem.21scon.46_abstract_saman.pdf.

Full text
Abstract:
Diabetes Mellitus is one of the endocrine diseases that most affect dogs in Brazil and worldwide. It is characterized by a chronic metabolic disorder, where the ability to respond or produce the hormone insulin is impaired, resulting in the abnormal activity of carbohydrate metabolism, coursing with hyperglycemia and glucosuria. The signs of 4P's (polyuria, polyphagia, polydipsia, and weight loss) are classic in this disease. As Diabetes Mellitus progresses, complications such as cataracts, retinopathy, and metabolic ketoacidosis may occur. Cataract is one of the most frequent complications in
APA, Harvard, Vancouver, ISO, and other styles
8

Myakina, Natalia E., Igor A. Lots, and Vadim V. Klimontov. "Continuous Glucose Monitoring Data Analysis in Insulin-Treated Type 1 And Type 2 Diabetic Subjects with the Use of Original Software." In 2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\Systems Biology (BGRS\SB). IEEE, 2018. http://dx.doi.org/10.1109/csgb.2018.8544878.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ibrahim, Khadega, Chiara Cugno, and Md Mizanur Rahman. "Conjugated Linoleic Acid (CLA) co-treatment alleviates antidiabetic drug, rosiglitazone associated deterioration of bone remodeling." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0148.

Full text
Abstract:
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia due to decreased insulin secretion, defective action or both. The rosiglitazone (RSG) is one of the oral antidiabetic drug used in type 2 (T2) DM and has a unique insulin-sensitizing capacity. However, RSG has a negative side effect on the bone as it stimulates the differentiation of bone marrow-mesenchymal stromal cells (BM-MSCs) into adipocytes at the expense of osteoblasts in the bone marrow microenvironment, disturbing the normal balance of bone remodeling and causing BM adiposity. On the other hand, the t
APA, Harvard, Vancouver, ISO, and other styles
10

Moreno, A., J. P. de la Cruz, J. Garcia Campos, and F. Sanchez de la Cuesta. "EFFECT OF DIPYRIDAMOLE + ASA ON THE RETINE VASCULAR PATTERN OF ESTREPTOZOTOCIN-DIABETIC RATS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643098.

Full text
Abstract:
INTRODUCTIONWe have used an experimental model which allows the evaluation of the qualitative differences in the retinal vascular pattern by means of the labeling of the retine vascular tree with radish peroxidase (HRP) in estreptozotocin-diabetic rats. The aim of the study was to evaluate the effect of ASA and DIP + ASA on the vessels platelet behaviour of said retine pattern in a group of rats in t-hich the diabetes had 3 months of evolution.PROCEDURE22 Wistar male rats were divided into A groups; 1) control group, 2) diabetic rats without antiaggregant, 3) dietetic rats treated with 6 mg/da
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Insulin Treated Diabetic"

1

Donahue, Katrina, Laura Young, John Buse, et al. Effect of Glucose Monitoring on Patient and Provider Outcomes in Non-Insulin Treated Diabetes. Patient-Centered Outcomes Research Institute (PCORI), 2018. http://dx.doi.org/10.25302/3.2018.ce.12114980.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hung, Hsuan-Yu, and Chung-Yu Chen. The impact of Sofosbuvir/Velpatasvir/Voxilaprevir treatment on serum hyperglycemia in HCV infections: A Systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.12.0109.

Full text
Abstract:
Review question / Objective: To assess the possible cause of events, the incidence of grade 3 hyperglycemia after treating Sofosbuvir/Velpatasvir/Voxilaprevir in HCV infections. Condition being studied: Sofosbuvir, velpatasvir, and voxilaprevir (SOF/VEL/VOX) is an effective, safe rescue therapy regimen for patients have previously been treated failure. Initiating Direct-Acting Antiviral (DAA) treatment for HCV infection with diabetes have experienced hypoglycemia, it could improve insulin resistance due to clean HCV. However, some studies shown that SOF/VEL/VOX has Grade 3 hyperglycemia advers
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!